[1] 余小杰,吴云,肖丽娜. 肝硬化上消化道出血医院感染患者预防性应用抗菌药物的观察. 中华医院感染学杂志,2013,23(9):2064-2066. [2] 吴诗品,于杰,彭红,等. 预防性抗生素应用对肝硬化并消化道出血患者医院感染的影响. 中华医院感染学杂志,2002,12(3):172-174. [3] 黄耀煊,邬光惠. 慢性乙型肝炎和肝硬化中乙型肝炎病毒X抗原表达的分析. 中华内科杂志,1995,23(4):235-238. [4] 科技部“十二五”重大专项联合课题组专家. 乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理. 中华消化杂志,2014,34(2):138-148. [5] 中华医学会传染病与寄生虫病学分会和肝病学分会. 病毒性肝炎防治方案.中华内科杂志,2001,40(1):324-329. [6] Chu CM.Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol,2010,15(s2):E25-E30. [7] Yao FY,Bass NM.Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol,2000,33(2):301-307. [8] Poon TC,Hui AY,Chan HL,et al.Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting:a pilot study. Clin Chem,2005,51(2):328-335. [9] Fattovich G,Boscaro S,Noventa F,et al.Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis,1987,155(5):931-935. [10] Tamura I,Kurimura O,Koda T,et al.Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection:a study from Kure,Japan. J Gastroenterol Hepatol,2010,8(5):433-436. [11] 徐黎. 乙型肝炎后肝硬化患者医院感染临床分析与护理干预. 中华医院感染学杂志,2013,23(1):103-105. [12] Bahr MJ,Manns MP.Function of the immune system in liver cirrhosis. Z Gastroenterol,2001,39(8):601-607. [13] Cao ZX,Chen XP,Wu ZD.Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma. Hepatobiliary Pancreatic Dis Int,2003,2(4):562. [14] Stassen WN,Mccullough AJ,Bacon BR,et al.Immediate diagnostic criteria for bacterial infection of ascitic fluid:Evaluation of ascitic fluid polymorphonuclear leukocyte count,pH,and lactate concentration,alone and in combination. Gastroenterology,1986,90(5 Pt 1):1247. [15] 杨茜,钟渊斌,张伦理. 慢性乙型肝炎患者医院感染病原菌分析与病原学研究. 中华医院感染学杂志,2015(12):2712-2714. [16] 赵芝萍,丘仲琼. 重型肝炎与肝硬化患者多重病原菌感染及危害. 中华医院感染学杂志,2009,19(20):2799-2800. [17] Tseng CW,Chang TT,Tzeng SJ,et al.Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C. Clin Interv Agingv,2016,11:327-334. [18] Amarapurkar DN,Kumar A,Murti P,et al.HIV infection in patients of liver cirrhosis. Indian J Med Res,1992,95(95):171. [19] Jain M,Chakravarti A,Kar P.Superinfection of hepatitis E virus as a cause of decompensation in liver cirrhosis due to hepatitis B virus. Asian Pac J Trop Med,2009,2(2):54-57. [20] Stanta G,Crocè LS,Bonin S,et al.Cohort effect of HCV infection in liver cirrhosis assessed by a 25 year study. J Clin Virol,2000,17(1):51-56. [21] Alempijevi T,Krsti M,Antoni V,et al.Frequency of helicobacter pylori infection in patients with liver cirrhosis. Srp Arh Celok Lek,2007,135(9-10):536-540. |